We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has c... Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. Show more
Ask ADVFN Intelligence (AI)
SAN FRANCISCO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery...
SAN FRANCISCO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.69 | -11.6161616162 | 5.94 | 5.9983 | 4.835 | 1700075 | 5.40899445 | CS |
| 4 | -1.58 | -23.1332357247 | 6.83 | 6.87 | 4.835 | 1315814 | 5.78968565 | CS |
| 12 | -7.13 | -57.5928917609 | 12.38 | 13.51 | 4.835 | 896451 | 7.81741217 | CS |
| 26 | -7.03 | -57.2475570033 | 12.28 | 16.62 | 4.835 | 716112 | 10.08199964 | CS |
| 52 | -6.1 | -53.7444933921 | 11.35 | 16.775 | 4.835 | 789867 | 11.09027345 | CS |
| 156 | -1.73 | -24.7851002865 | 6.98 | 17.7911 | 2 | 511222 | 9.48477 | CS |
| 260 | -41.75 | -88.829787234 | 47 | 60.27 | 2 | 467322 | 12.32367006 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
